国产新减肥药上市,赛道竞争加剧!

制药网
16 Jul

【制药网 行业动态】近日,信达生物的减肥药“玛仕度肽”在北京大学人民医院开出全国首张处方。此前的6月27日,国家药品监督管理局批准了玛仕度肽注射液上市,其适应症明确为成人肥胖或超重患者的长期体重控制。这一消息迅速在减肥领域掀起波澜,让本就竞争激烈的减肥药赛道火药味更浓。玛仕度肽是全球头个获批的胰高血糖素(GCG)/胰高血糖素样肽-1(GLP-1)双受体激动剂,其双激动作用机制堪称减重领域的一大突破...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10